{
 "url": "https://etfiq.com/funds/gnmx/holdings/",
 "section": "funds",
 "title": "GNMX Holdings: All 57 Positions (Oct 14, 2026) | ETFIQ",
 "description": "All 57 GNMX holdings with weights, as of Oct 14, 2026. The top 3 are MRNA 10.29%, TMO 8.85% and VRTX 5.73%. Download the full list as a CSV.",
 "as_of": "Oct 14, 2026",
 "ticker": "GNMX",
 "fund": "Corgi Genomics & Precision Medicine ETF",
 "fund_page": "https://etfiq.com/funds/gnmx",
 "positions": 57,
 "positions_listed_on_page": 57,
 "lead": "GNMX held 57 positions as of Oct 14, 2026. Moderna Inc is the largest at 10.29%; the top 10 are 48.6% of the fund.",
 "source": {
  "name": "Corgi",
  "url": "https://corgiinvest.com/api/data/holdings?ticker=GNMX",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-14",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 10.29,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 2,
   "holding": "Thermo Fisher Scientific Inc",
   "ticker": "TMO",
   "weight_pct": 8.85,
   "page": "https://etfiq.com/holdings/tmo/"
  },
  {
   "rank": 3,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 5.73,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 4,
   "holding": "Illumina Inc",
   "ticker": "ILMN",
   "weight_pct": 4.91,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 5,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 3.48,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 6,
   "holding": "Revolution Medicines Inc",
   "ticker": "RVMD",
   "weight_pct": 3.29,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 7,
   "holding": "10X Genomics Inc",
   "ticker": "TXG",
   "weight_pct": 3.24,
   "page": "https://etfiq.com/holdings/txg/"
  },
  {
   "rank": 8,
   "holding": "Iovance Biotherapeutics Inc",
   "ticker": "IOVA",
   "weight_pct": 3.17,
   "page": "https://etfiq.com/holdings/iova/"
  },
  {
   "rank": 9,
   "holding": "Genmab A/S",
   "ticker": "GMAB",
   "weight_pct": 3.07,
   "page": "https://etfiq.com/holdings/gmab/"
  },
  {
   "rank": 10,
   "holding": "Incyte Corp",
   "ticker": "INCY",
   "weight_pct": 2.57,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 11,
   "holding": "Twist Bioscience Corp",
   "ticker": "TWST",
   "weight_pct": 2.52,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 12,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 2.46,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 13,
   "holding": "GRAIL Inc",
   "ticker": "GRAL",
   "weight_pct": 2.3,
   "page": "https://etfiq.com/holdings/gral/"
  },
  {
   "rank": 14,
   "holding": "Bio-Techne Corp",
   "ticker": "TECH",
   "weight_pct": 2.18,
   "page": "https://etfiq.com/holdings/tech/"
  },
  {
   "rank": 15,
   "holding": "Qiagen N.V.",
   "ticker": "QGEN",
   "weight_pct": 1.95,
   "page": "https://etfiq.com/holdings/qia/"
  },
  {
   "rank": 16,
   "holding": "CareDx Inc",
   "ticker": "CDNA",
   "weight_pct": 1.91,
   "page": "https://etfiq.com/holdings/cdna/"
  },
  {
   "rank": 17,
   "holding": "BioMarin Pharmaceutical Inc",
   "ticker": "BMRN",
   "weight_pct": 1.9,
   "page": "https://etfiq.com/holdings/bmrn/"
  },
  {
   "rank": 18,
   "holding": "Krystal Biotech Inc",
   "ticker": "KRYS",
   "weight_pct": 1.81,
   "page": "https://etfiq.com/holdings/krys/"
  },
  {
   "rank": 19,
   "holding": "Tempus AI Inc",
   "ticker": "TEM",
   "weight_pct": 1.76,
   "page": "https://etfiq.com/holdings/tem/"
  },
  {
   "rank": 20,
   "holding": "Adaptive Biotechnologies Corp",
   "ticker": "ADPT",
   "weight_pct": 1.66,
   "page": "https://etfiq.com/holdings/adpt/"
  },
  {
   "rank": 21,
   "holding": "NeoGenomics Inc",
   "ticker": "NEO",
   "weight_pct": 1.35,
   "page": "https://etfiq.com/holdings/neo/"
  },
  {
   "rank": 22,
   "holding": "Caris Life Sciences Inc",
   "ticker": "CAI",
   "weight_pct": 1.33,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Arrowhead Pharmaceuticals Inc",
   "ticker": "ARWR",
   "weight_pct": 1.31,
   "page": "https://etfiq.com/holdings/arwr/"
  },
  {
   "rank": 24,
   "holding": "CRISPR Therapeutics AG",
   "ticker": "CRSP",
   "weight_pct": 1.29,
   "page": "https://etfiq.com/holdings/crsp/"
  },
  {
   "rank": 25,
   "holding": "Veracyte Inc",
   "ticker": "VCYT",
   "weight_pct": 1.26,
   "page": "https://etfiq.com/holdings/vcyt/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "First American Government Obligations Fund 12/01/2031",
   "weight_pct": 2.59
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.01
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/gnmx/holdings/gnmx-holdings.csv",
 "json_book": "https://etfiq.com/data/books/gnmx.json",
 "markdown": "https://etfiq.com/funds/gnmx/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of GNMX, data as of Oct 14, 2026. https://etfiq.com/funds/gnmx/holdings/"
}